Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss 28-08-2025, 19:30

Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit 7-01-2026, 01:34

EBC Financial Group Recognised as “Most Trusted FX Broker” and “Best CFD Broker” at World Finance Awards 26-06-2024, 17:33